Actos Lawsuit News: Bernstein Liebhard LLP Reports on Upcoming Status Conference in Federal Actos Bladder Cancer Litigation

Share Article

The Firm continues to investigate Actos bladder cancer lawsuits on behalf of long-term Actos users.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We are pleased to see this litigation moving forward, as our Firm continues to receive inquiries from individuals who may have developed bladder cancer due to their long-term use of Actos,

Thousands of Actos lawsuits filed on behalf of individuals who allegedly suffered bladder cancer due to long –term use of the type 2 diabetes drug continue to move forward in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to a Minute Entry posted on the Court’s website on April 17th, the litigation’s next Status Conference is scheduled for April 25th. Among other things, the Conference will address the status of federal and state Actos bladder cancer filings, as well as the status of the bellwether trial nomination process. Court documents indicate the first trial in the federal Actos litigation will begin in January 2014. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We are pleased to see this litigation moving forward, as our Firm continues to receive inquiries from individuals who may have developed bladder cancer due to their long-term use of Actos,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Actos bladder cancer lawsuit evaluations to any Actos user who developed this disease.

Actos Bladder Cancer Lawsuits
Court records indicate that Takeda Pharmaceuticals has been named in more than 3,000 Actos bladder cancer lawsuits, most of which are pending in the Western District of Louisiana. All of the Actos lawsuits allege that users of the drug face an increased risk of developing bladder cancer. Plaintiffs also accuse Takeda and other defendants of concealing their knowledge of that risk and failing to provide adequate warnings to the public and medical community.

Last week, a Los Angeles Superior Court jury heard closing arguments in the nation’s first trial of an Actos bladder cancer trial. According to a report, evidence introduced at trial included internal Takeda emails that suggested company officials were worried about the impact an Actos bladder cancer warning would have on sales of the drug. Documents unsealed ahead of the trial also indicate Takeda secretly surveyed a dozen doctors in 2003 to see if they would prescribe a diabetes drug that carried a warning about the potential for bladder cancer. Plaintiff’s attorneys assert the survey found that a bladder cancer warning would destroy the sales of Takeda’s most important drug, Bloomberg said.* (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

In June 2011, the U.S. Food & Drug Administration (FDA) ordered Takeda to add new warnings to the Actos label, after a study found that long-term use of the drug increased the risk for bladder cancer.** Since the FDA issued its alert, the evidence tying Actos to an increased risk of bladder cancer has only grown.    Most recently, a study published in the British Diabetic Association journal, “Diabetic Medicine,” found that the risk of bladder cancer was significantly higher in patients using Actos compared with control groups.***

Actos users who developed bladder cancer may be entitled to file an Actos lawsuit to obtain compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos bladder cancer lawsuit by visiting Bernstein Liebhard LLP’s website, or contact one of our attorneys by calling (877) 779-1414.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website